| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |